| Immune system and melanoma biology: a balance between immunosurveillance and immune escape A Passarelli, F Mannavola, LS Stucci, M Tucci, F Silvestris Oncotarget 8 (62), 106132, 2017 | 250 | 2017 |
| Immune system evasion as hallmark of melanoma progression: the role of dendritic cells M Tucci, A Passarelli, F Mannavola, C Felici, LS Stucci, M Cives, ... Frontiers in oncology 9, 1148, 2019 | 127 | 2019 |
| Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity M Tucci, F Mannavola, A Passarelli, LS Stucci, M Cives, F Silvestris Oncotarget 9 (29), 20826, 2018 | 120 | 2018 |
| Immune‑related adverse events during anticancer immunotherapy: Pathogenesis and management S Stucci, R Palmirotta, A Passarelli, E Silvestris, A Argentiero, L Lanotte, ... Oncology Letters 14 (5), 5671-5680, 2017 | 92 | 2017 |
| Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma M Tucci, A Passarelli, F Mannavola, LS Stucci, PA Ascierto, M Capone, ... Oncoimmunology 7 (2), e1387706, 2018 | 91 | 2018 |
| The immune escape in melanoma: role of the impaired dendritic cell function M Tucci, S Stucci, A Passarelli, G Giudice, F Dammacco, F Silvestris Expert review of clinical immunology 10 (10), 1395-1404, 2014 | 57 | 2014 |
| Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis F Mannavola, M Tucci, C Felici, A Passarelli, S D’Oronzo, F Silvestris Journal of translational medicine 17, 1-15, 2019 | 50 | 2019 |
| Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? F Mannavola, T Salerno, A Passarelli, M Tucci, V Internò, F Silvestris Frontiers in Oncology 9, 521, 2019 | 47 | 2019 |
| Avβ3 integrin: Pathogenetic role in osteotropic tumors S Stucci, M Tucci, A Passarelli, F Silvestris Critical Reviews in Oncology/Hematology 96 (1), 183-193, 2015 | 46 | 2015 |
| The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine A Passarelli, M Tucci, F Mannavola, C Felici, F Silvestris Tumor Biology 41 (4), 1010428319837138, 2019 | 39 | 2019 |
| Targeting immunometabolism mediated by CD73 pathway in EGFR-mutated Non-Small Cell Lung Cancer: A new hope for overcoming immune resistance A Passarelli, M Aieta, A Sgambato, C Gridelli Frontiers in Immunology 1, doi: 10.3389/fimmu.2020.01479, 2020 | 38 | 2020 |
| The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma M Tucci, A Passarelli, A Todisco, F Mannavola, LS Stucci, S D’Oronzo, ... Therapeutic Advances in Medical Oncology 11, 1758835919875549, 2019 | 33 | 2019 |
| Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of … G D’Arena, V Simeon, L Laurenti, M Cimminiello, I Innocenti, M Gilio, ... Leukemia & Lymphoma 58 (11), 2633-2641, 2017 | 27 | 2017 |
| Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015 VGY Nanda, W Peng, P Hwu, MA Davies, G Ciliberto, L Fattore, ... Journal of Translational Medicine 14, 1-27, 2016 | 16 | 2016 |
| Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer A Passarelli, C Pisano, SC Cecere, M Di Napoli, S Rossetti, R Tambaro, ... Frontiers in immunology 13, 953115, 2022 | 14 | 2022 |
| Relationship between lumbar lordosis, pelvic parameters, PI-LL mismatch and outcome after short fusion surgery for lumbar degenerative disease. Literature review, rational and … F Tartara, D Garbossa, D Armocida, G Di Perna, M Ajello, N Marengo, ... World Neurosurgery: X 18, 100162, 2023 | 13 | 2023 |
| Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma M Tucci, LS Stucci, F Mannavola, A Passarelli, S D’Oronzo, L Lospalluti, ... Clinical and Translational Oncology 21, 845-854, 2019 | 13 | 2019 |
| A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature A Passarelli, G Galdo, M Aieta, T Fabrizio, A Villonio, R Conca International Journal of Molecular Sciences 21, https://doi.org/10.3390 …, 2020 | 12 | 2020 |
| Vulvar Paget’s Disease: a systematic review of the MITO Rare Cancer Group G Caruso, A Barcellini, R Mazzeo, R Gallo, MG Vitale, A Passarelli, ... Cancers 15 (6), 1803, 2023 | 10 | 2023 |
| A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group M Bartoletti, A Bergamini, G Giannone, C Nero, L Musacchio, A Farolfi, ... International Journal of Gynecological Cancer 32 (9), 1205-1207, 2022 | 10 | 2022 |
